Eton Pharmaceuticals, Inc. (ETON)
63.16
-1.27
(-1.97%)
USD |
NASDAQ |
Aug 25, 14:00
Eton Pharmaceuticals Max Drawdown (5Y) : 79.94% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 79.94% |
| June 30, 2026 | 79.94% |
| May 31, 2026 | 79.94% |
| April 30, 2026 | 79.94% |
| March 31, 2026 | 79.94% |
| February 28, 2026 | 79.94% |
| January 31, 2026 | 79.94% |
| December 31, 2025 | 79.94% |
| November 30, 2025 | 79.94% |
| October 31, 2025 | 79.94% |
| September 30, 2025 | 79.94% |
| August 31, 2025 | 79.94% |
| July 31, 2025 | 79.94% |
| June 30, 2025 | 79.94% |
| May 31, 2025 | 79.94% |
| April 30, 2025 | 79.94% |
| March 31, 2025 | 79.94% |
| February 28, 2025 | 79.94% |
| January 31, 2025 | 79.94% |
| December 31, 2024 | 79.94% |
| November 30, 2024 | 79.94% |
| October 31, 2024 | 79.94% |
| September 30, 2024 | 79.94% |
| August 31, 2024 | 79.94% |
| July 31, 2024 | 79.94% |
| Date | Value |
|---|---|
| June 30, 2024 | 79.94% |
| May 31, 2024 | 79.94% |
| April 30, 2024 | 79.94% |
| March 31, 2024 | 79.94% |
| February 29, 2024 | 79.94% |
| January 31, 2024 | 79.94% |
| December 31, 2023 | 79.94% |
| November 30, 2023 | 79.94% |
| October 31, 2023 | 79.94% |
| September 30, 2023 | 79.94% |
| August 31, 2023 | 79.94% |
| July 31, 2023 | 79.94% |
| June 30, 2023 | 79.94% |
| May 31, 2023 | 79.94% |
| April 30, 2023 | 79.94% |
| March 31, 2023 | 79.94% |
| February 28, 2023 | 79.94% |
| January 31, 2023 | 79.94% |
| December 31, 2022 | 79.94% |
| November 30, 2022 | 79.94% |
| October 31, 2022 | 79.94% |
| September 30, 2022 | 79.74% |
| August 31, 2022 | 77.56% |
| July 31, 2022 | 74.68% |
| June 30, 2022 | 74.68% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Nektar Therapeutics | 99.39% |
| Pfizer Inc. | 58.95% |
| Elite Pharmaceuticals, Inc. | 87.92% |
| Daré Bioscience, Inc. | 95.72% |
| Liquidia Corp. | 93.87% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 43.71 |
| Beta (5Y) | 0.8607 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 68.42% |
| Historical Sharpe Ratio (5Y) | 0.7546 |
| Historical Sortino (5Y) | 1.904 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.67% |